Susan Fotheringham Department of Medical Oncology Dana-Farber Cancer Institute Biography Publications Institution JoVE Articles Susan Fotheringham has not added a biography. If you are Susan Fotheringham and would like to personalize this page please email our Author Liaison for assistance. Publications HR23B Est Un Biomarqueur De La Sensibilité De La Tumeur à La Thérapie Axée Sur L'inhibiteur D'HDAC Proceedings of the National Academy of Sciences of the United States of America. Apr, 2010 | Pubmed ID: 20308564 Génome-large Perte De Fonction écran Révèle Un Rôle Important Pour Le Protéasome Dans L'apoptose Induite Par L'inhibiteur D'HDAC Cancer Cell. Jan, 2009 | Pubmed ID: 19111881 Culture ex vivo des cellules humaines primaires épithéliales des trompes de Fallope Susan Fotheringham1,2, Keren Levanon1,2,3, Ronny Drapkin1,2,4 1Department of Medical Oncology, Dana-Farber Cancer Institute, 2Harvard Medical School, Boston, MA, 3Sheba Cancer Research Center, Chaim Sheba Medical Center, 4Department of Pathology, Brigham and Women's Hospital JoVE 2728 Biologie
Culture ex vivo des cellules humaines primaires épithéliales des trompes de Fallope Susan Fotheringham1,2, Keren Levanon1,2,3, Ronny Drapkin1,2,4 1Department of Medical Oncology, Dana-Farber Cancer Institute, 2Harvard Medical School, Boston, MA, 3Sheba Cancer Research Center, Chaim Sheba Medical Center, 4Department of Pathology, Brigham and Women's Hospital JoVE 2728 Biologie